对Trametinib的FDA不良事件报告系统事件的现实世界药监测研究
Xinyue Zhang1, Rongrong Li1, Yanrong Li1
1Oncology, Guangxi University of Chinese Medicine, Nanning, CHN.
Cureus
|September 27, 2024
概括
这项研究分析了FDA不良事件报告系统数据,以识别与特拉美替尼相关的不良药物事件 (ADEs). 瘤和与调查相关的事件很常见,并发现了新的副作用,如乳头炎.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 特拉美替尼布是一种用于癌症治疗的向疗法.
- 了解其不良药物事件 (ADEs) 对患者安全至关重要.
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 是药物监测的宝贵资源.
研究的目的:
- 为了调查与美丁尼布相关的ADEs.
- 分析使用FAERS数据从2013年第二季度到2023年第四季度的特拉美替尼相关的ADEs.
- 识别潜在的安全信号和以前未知的不良反应.
主要方法:
- 从FAERS数据库中提取与特拉美替尼相关的ADEs的数据.
- 收集的ADE数据的标准化.
- 应用统计方法,包括报告几率比率 (ROR),比例报告比率 (PRR),神经网络贝叶斯信任传播 (BCPNN) 和多项马波森收缩器 (MGPS) 来检测安全信号.
主要成果:
- 对2200份ADE报告的分析确定了23个器官系统分类中的191个不良反应术语.
- 最常见的分类是一般性疾病/注射部位状况 (1254例),瘤 (802例) 和调查 (794例).
- 确定了以前未被标记的不良反应,包括炎,叶状炎,性角膜炎和斯特里多.
结论:
- 特拉梅替尼布虽然在治疗上有益,但与各种潜在的不良反应有关.
- 医疗保健提供者应积极监测患者的特殊症状,如乳头炎,叶状泛炎,性角膜炎和.
- 在治疗中对其他不良事件保持警对于安全的患者管理至关重要.
关键词:
不良事件是不良事件.费尔斯·费尔斯 (Faers Faers) 是一个非常古老的城市.疲劳 疲劳 疲劳 疲劳 疲劳 疲劳这种高血压,高血压.甲状腺功能低下症 甲状腺功能低下症特拉美丁尼布 (trametinib) 是一种药物.氨酸激酶抑制剂 氨酸激酶抑制剂更多相关视频
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
806
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
7.9K
相关概念视频
01:19Pharmacovigilance
786
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
786
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:16Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K